Auna S.A.在收入和股票业绩方面击败了Ryman保健公司,但在财务上追逐了其他竞争对手。 Auna S.A. beats Ryman Healthcare in revenue and stock performance but trails other competitors financially.

Auna S.A.是拉丁美洲的保健服务提供者,其收入和收益高于另一家小公司Ryman Healthcare Limited。 Auna S.A., a healthcare provider in Latin America, has higher revenue and earnings than Ryman Healthcare Limited, another small-cap medical company. Auna的股票更加不稳定,带来更强劲的红利和更高的分析师建议。 Auna's stock is more volatile and offers a stronger dividend and higher analyst recommendations. 然而,与竞争对手相比,Auna的收入、收入以及净利润和股本回报等关键金融衡量标准都较低,尽管其股票波动性更大。 However, when compared to its competitors, Auna has lower revenue, earnings, and key financial metrics like net margins and return on equity, despite its higher stock volatility. 总的来说,Auna的业绩优于Ryman保健,但在多数金融衡量标准方面落后于其主要竞争者。 Overall, Auna outperforms Ryman Healthcare but lags behind its main competitors in most financial metrics.